stockrowAscendis Pharma A/S
ASND Healthcare Biotechnology
Ascendis Pharma A/S’s revenue for fiscal 2025 (year ended December 2025) was $814.8 million, up 107.1% from fiscal 2024.
- Revenue
- +119.9%
- EPS
- +612.3%
- Free cash flow
- +2,335.9%
- Total debt
- −41.8%
Quarter to June 2026, against a year earlier
Follow ASND
Alert me
Ascendis Pharma A/S (ASND) Operating margin
Ascendis Pharma A/S's operating margin over the twelve months to 30 June 2026 was 24.8%, up 43.8 percentage points from fiscal 2025 (−18.9%). Over the past ten years it has ranged from −7,290.1% (fiscal 2017) to −18.9% (fiscal 2025) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −18.9% | 57.74 |
| FY2024 | −76.7% | 94.13 |
| FY2023 | −170.8% | 927.06 |
| FY2022 | −1,097.9% | 4,710.71 |
| FY2021 | −5,808.6% | (1,053.48) |
| FY2020 | −4,755.1% | (3,059.98) |
| FY2019 | −1,695.1% | (232.51) |
| FY2018 | −1,462.6% | 5,827.50 |
| FY2017 | −7,290.1% | (5,706.94) |
| FY2016 | −1,583.2% | (1,067.94) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 65.0% | 54.92 |
| Mar 2026 | 10.1% | 9.03 |
| Dec 2025 | 1.03% | (4.12) |
| Sep 2025 | 5.15% | 38.65 |
| 42 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| EXEL Exelixis, Inc. compare | 40.2% |
| HALO Halozyme Therapeutics, Inc. compare | 37.4% |
| ASND Ascendis Pharma A/S | 24.8% |
| ALNY Alnylam Pharmaceuticals, Inc. compare | 19.5% |
| JAZZ Jazz Pharmaceuticals PLC compare | 9.03% |
| SMMT Summit Therapeutics PLC compare | 0.00% |
| INSM Insmed, Inc. compare | −37.1% |
| BBIO BridgeBio Pharma, Inc. compare | −38.5% |
| BNTX BioNTech SE Sponsored ADR compare | −79.0% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on ASND
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement